Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Prepaid Assets (2017 - 2025)

Inmune Bio (INMB) has disclosed Prepaid Assets for 9 consecutive years, with $595000.0 as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 79.76% to $595000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $595000.0 through Dec 2025, up 79.76% year-over-year, with the annual reading at $595000.0 for FY2025, 79.76% up from the prior year.
  • Prepaid Assets hit $595000.0 in Q4 2025 for Inmune Bio, up from $472000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $4.7 million in Q1 2022 to a low of $30000.0 in Q2 2023.
  • Historically, Prepaid Assets has averaged $1.8 million across 5 years, with a median of $1.3 million in 2021.
  • Biggest five-year swings in Prepaid Assets: crashed 99.29% in 2023 and later surged 3276.67% in 2024.
  • Year by year, Prepaid Assets stood at $2.3 million in 2021, then soared by 76.78% to $4.0 million in 2022, then plummeted by 62.5% to $1.5 million in 2023, then tumbled by 78.08% to $331000.0 in 2024, then surged by 79.76% to $595000.0 in 2025.
  • Business Quant data shows Prepaid Assets for INMB at $595000.0 in Q4 2025, $472000.0 in Q3 2025, and $505000.0 in Q2 2025.